Skip to main content

Aravive, Inc.

ARAVDelisted Jan 29, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001513818

Aravive, Inc. was delisted on Jan 29, 2024; its insiders filed their last Form 4 on Apr 11, 2023; 30 institutions reported holding it in 13F filings for Q4 2023, worth $825.5K in total; no superinvestor held it.

Q4 2021 vs. Q3 2021

How the institutions holding Aravive, Inc. changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of ARAV: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders4536−9
Shares4.75M4.56M−193.9K (−4.1%)
Value$17.7M$9.99M−$7.70M (−43.5%)

New holders (2)

Institutions that held Aravive, Inc. at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to ARAV in Q4 2021
InstitutionSharesValue% of portfolio
Two Sigma Securities, LLC12,551$27.0K0.01%
FMR LLC650$1.00K0.00%

Sold out (11)

Institutions that held Aravive, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of ARAV in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Ergoteles LLC57,598$214.0K
Blair William & Co43,000$160.0K
Marshall Wace, LLP28,462$106.0K
HRT Financial LP26,749$99.0K
Walleye Trading LLC14,371$53.0K
Jacobs Levy Equity Management, Inc12,127$45.0K
Virtu Financial LLC10,861$40.0K
Advisor Group Holdings, Inc.2,269$8.00K
Barclays PLC1,678$6.00K
Cutler Group LP700$2.00K
Royal Bank of Canada33$0